Receive our newsletter – data, insights and analysis delivered to you
  1. News
February 14, 2017

Promega, Hitachi High Technologies develop new Spectrum CE instrument for DNA analysis

Promega Corporation has developed a benchtop capillary electrophoresis (CE) instrument in collaboration with Hitachi High-Technologies Corporation.

Promega Corporation has developed a benchtop capillary electrophoresis (CE) instrument in collaboration with Hitachi High-Technologies Corporation.

Called Spectrum Compact CE System, it meets small batch and single sample needs in DNA analysis and performs both sequencing and fragment analysis at a moment’s notice.

Ideal for laboratories of all sizes, the new system conducts single nucleotide polymorphism, PCR sizing and microsatellite analysis, de novo sequencing, NGS validation and mutation detection.

Equipped with the four-capillary, six-dye detection characteristics and an integrated touch-screen for  operation, the instrument is designed to run approximately 32 samples simultaneously.

Promega Nucleic Acid Technologies research head Doug Storts said: “This opens new possibilities to scientists seeking high quality DNA detection on a smaller scale.

“This system supports the unique workflows of the lab versus the lab needing to batch samples as a work around and cost savings measure when using a high-throughput instrument or service.

Content from our partners
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
“This technique means everything to us”: How CGM devices empower users 
Ensuring quality and supply chain visibility for medical device components

"When we ask for early input from labs worldwide, the consistent response we get from scientists is ‘thank you’.”

The CE intrument also features plug-and-play prefilled reagent cartridges with a guided software user interface that is claimed to make the usage of the instrument easy.

"The new system conducts single nucleotide polymorphism, PCR sizing and microsatellite analysis, de novo sequencing, NGS validation and mutation detection."

While the firm plans to display the first prototype in February, the compact instrument is estimated to be available commercially in the second half of 2017.

The collaboration between Promega and Hitachi High-Technologies is expected to leverage their respective strengths to provide a high-performing, high-value, compact capillary electrophoresis instrument.

Promega intends to further launch a new Sanger sequencing kit with enhanced base-calling accuracy, to support the Spectrum compact CE system.


Image: Promega's new Spectrum compact CE system. Photo: courtesy of Business Wire/Promega Corporation.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU